Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This study will be undertaken to evaluate the feasibility of replacing systemic Androgen
Deprivation Therapy (ADT) with targeted local delivery of an anti-androgen agent alone in
patients in whom ADT + radiation therapy is indicated for the treatment of localized prostate
cancer.